title: [Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer].
authors.forename: Z
authors.initials: Z
authors.lastname: Hernádi
authors.forename: B
authors.initials: B
authors.lastname: Juhász
authors.forename: R
authors.initials: R
authors.lastname: Póka
authors.forename: I
authors.initials: I
authors.lastname: Mahunka
authors.forename: L
authors.initials: L
authors.lastname: Lampé
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D015251:Epirubicin; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010440:Peptichemio / Q000009:adverse effects / Q000627:therapeutic use; D011897:Random Allocation
chemical_list: D015251:Epirubicin; D004317:Doxorubicin; D003520:Cyclophosphamide; D010440:Peptichemio
vernacular_title: A CAP és CEP gyógyszerkombinációk hatékonyságának és mellékhatásainak vizsgálata elörehaladott stádiumú petefészekrákos betegek kezelése során.